Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Buller

Showing results (151-160 of 183) with videos related to

Pageof 19
Sort By:
Biochemistry|September 3, 2025
18-Crown-6-ether Utilizes Distinct Allosteric Interactions to Uncouple Transport by the Multidrug Efflux Pump EmrEMerissa Brousseau, Tapasyatanu Dash, Michael J Rourke, et al.
Thrombosis and Haemostasis|January 25, 2008
Further validation and simplification of the Wells clinical decision rule in pulmonary embolismNadine S Gibson, Maaike Sohne, Marieke J H A Kruip, et al.
Blood|July 16, 2008
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging StudyHarry R Buller, Anthonie W A Lensing, Martin H Prins, et al.
The Biochemical Journal|April 8, 2015
Cofactor specificity motifs and the induced fit mechanism in class I ketol-acid reductoisomerasesJackson K B Cahn, Sabine Brinkmann-Chen, Thomas Spatzal, et al.
Advances in Experimental Medicine and Biology|January 1, 1990
Endotoxin-induced cytokines in human septicemiaI de Vries, S J van Deventer, J Debets, et al.
International Angiology : a Journal of the International Union of Angiology|July 1, 1992
Prevention of venous thromboembolism. European Consensus Statement, 1-5 November 1991, developed at Oakley Court Hotel, Windsor, UKA N Nicolaides, J Arcelus, G Belcaro, et al.
The New England Journal of Medicine|September 15, 2007
Idraparinux versus standard therapy for venous thromboembolic disease, Harry R Buller, Ander T Cohen, et al.
The New England Journal of Medicine|September 15, 2007
Extended prophylaxis of venous thromboembolism with idraparinux, Harry R Buller, Ander T Cohen, et al.
Blood|June 17, 2006
A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutationMichiel Coppens, Marlene H van de Poel, Ivan Bank, et al.
The New England Journal of Medicine|July 2, 2013
Oral apixaban for the treatment of acute venous thromboembolismGiancarlo Agnelli, Harry R Buller, Alexander Cohen, et al.
Pageof 19

Showing results (151-160 of 183) with videos related to

Sort By:
Pageof 19
Biochemistry|September 3, 2025
18-Crown-6-ether Utilizes Distinct Allosteric Interactions to Uncouple Transport by the Multidrug Efflux Pump EmrEMerissa Brousseau, Tapasyatanu Dash, Michael J Rourke, et al.
Thrombosis and Haemostasis|January 25, 2008
Further validation and simplification of the Wells clinical decision rule in pulmonary embolismNadine S Gibson, Maaike Sohne, Marieke J H A Kruip, et al.
Blood|July 16, 2008
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging StudyHarry R Buller, Anthonie W A Lensing, Martin H Prins, et al.
The Biochemical Journal|April 8, 2015
Cofactor specificity motifs and the induced fit mechanism in class I ketol-acid reductoisomerasesJackson K B Cahn, Sabine Brinkmann-Chen, Thomas Spatzal, et al.
Advances in Experimental Medicine and Biology|January 1, 1990
Endotoxin-induced cytokines in human septicemiaI de Vries, S J van Deventer, J Debets, et al.
International Angiology : a Journal of the International Union of Angiology|July 1, 1992
Prevention of venous thromboembolism. European Consensus Statement, 1-5 November 1991, developed at Oakley Court Hotel, Windsor, UKA N Nicolaides, J Arcelus, G Belcaro, et al.
The New England Journal of Medicine|September 15, 2007
Idraparinux versus standard therapy for venous thromboembolic disease, Harry R Buller, Ander T Cohen, et al.
The New England Journal of Medicine|September 15, 2007
Extended prophylaxis of venous thromboembolism with idraparinux, Harry R Buller, Ander T Cohen, et al.
Blood|June 17, 2006
A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutationMichiel Coppens, Marlene H van de Poel, Ivan Bank, et al.
The New England Journal of Medicine|July 2, 2013
Oral apixaban for the treatment of acute venous thromboembolismGiancarlo Agnelli, Harry R Buller, Alexander Cohen, et al.
Pageof 19